Ergoloid mesylates

Ergoloid Mesylates are a mixture of alkaloids produced synthetically from ergot, a fungus that grows on rye. They are used primarily as a treatment for symptoms related to Alzheimer's disease and other forms of dementia.

History

Ergoloid Mesylates were first synthesized in the late 1940s by Albert Hofmann, the same chemist who discovered LSD. They were approved by the Food and Drug Administration (FDA) in 1951 and have been used in the treatment of dementia and related conditions ever since.

Pharmacology

Ergoloid Mesylates work by increasing blood flow to the brain and enhancing the metabolism of brain cells. They are believed to improve cognitive function and reduce symptoms of dementia by increasing the availability of neurotransmitters in the brain.

Medical Uses

Ergoloid Mesylates are used primarily in the treatment of symptoms related to Alzheimer's disease and other forms of dementia. They may also be used to treat conditions related to poor circulation in the brain, such as vertigo, mood disturbances, and age-related cognitive decline.

Side Effects

Common side effects of Ergoloid Mesylates include nausea, stomach upset, and skin rash. In rare cases, they can cause more serious side effects such as hallucinations, irregular heartbeat, and severe allergic reactions.

Contraindications

Ergoloid Mesylates should not be used by individuals with known hypersensitivity to ergot alkaloids. They should also be used with caution in individuals with severe liver or kidney disease.

See Also

• Ergot
• Alzheimer's disease
• Dementia
• Pharmacology
• Food and Drug Administration

‎